Barclays Sticks to Its Buy Rating for Camden Property (CPT)
In a report released today, Richard Hightower from Barclays maintained a Buy rating on Camden Property (CPT – Research Report), with a price ...
Needham & Company LLC Reaffirms “Hold” Rating for Affirm (NASDAQ:AFRM)
Affirm (NASDAQ:AFRM – Get Free Report)‘s stock had its “hold” rating reaffirmed by Needham & Company LLC in a note issued to ...
RBC Capital Sticks to Its Buy Rating for Reckitt (RKT)
In a report released today, James Edwardes Jones from RBC Capital maintained a Buy rating on Reckitt (RKT – Research Report), with a price ...
Comerica's SWOT analysis: stock faces deposit challenges amid rate shifts
Comerica Incorporated (NYSE:CMA), a Texas-based regional bank with significant presence in Michigan and California, finds itself at a crossroads as it navigates a complex financial landscape. With ...
Zimmer Biomet's SWOT analysis: medical device maker's stock faces ERP hurdles
Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a leading player in the medical devices industry with a market capitalization of $22.08 billion, has been navigating a complex landscape of operational ...
Beyond The Numbers: 7 Analysts Discuss Zimmer Biomet Holdings Stock
The 12-month price targets, analyzed by analysts, offer insights with an average target of $123.0, a high estimate of $138.00, and a low estimate of $117.00. Witnessing a positive shift, the current ...